![Allison Dorval](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Allison Dorval
Directeur/Membre du Conseil chez
PUMA BIOTECHNOLOGY, INC.
Fortune : 540 546 $ au 31/05/2026
Profil
Allison Dorval is currently an Independent Director at Puma Biotechnology, Inc. since 2021.
Former positions include Independent Director at Jade Biosciences, Inc. from 2021 to 2025; Vice President & Controller at Catalent JNP, Inc. from 2016 to 2017; Chief Financial Officer at Arsenal Medical, Inc. from 2015 to 2016; Chief Financial Officer at Lyra Therapeutics, Inc. from 2015 to 2016; Chief Financial Officer at Insulet Corp.
from 2014 to 2015; Chief Financial & Accounting Officer at Verve Therapeutics, Inc. from 2021 to 2025; Chief Financial Officer at Voyager Therapeutics, Inc. from 2018 to 2021; Finance Director at Digitas, Inc.; Assistant Controller at iBASIS, Inc.; and Principal at PricewaterhouseCoopers LLP.
Education includes undergraduate studies at the University of Vermont.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PUMA BIOTECHNOLOGY, INC. 0,15 % | 13/04/2026 | 75 390 ( 0,15 % ) | 540 546 $ | 31/05/2026 |
Postes actifs de Allison Dorval
| Sociétés | Poste | Début |
|---|---|---|
| PUMA BIOTECHNOLOGY, INC. | Directeur/Membre du Conseil | 15/07/2021 |
Anciens postes connus de Allison Dorval
| Sociétés | Poste | Fin |
|---|---|---|
| VERE THER | Directeur Financier/CFO | 25/07/2025 |
| JADE BIOSCIENCES, INC. | Directeur/Membre du Conseil | 28/04/2025 |
| VOYAGER THERAPEUTICS, INC. | Directeur Financier/CFO | 01/11/2021 |
| JUNIPER PHARMACEUTICALS INC | Comptroller/Controller/Auditor | 01/06/2017 |
| LYRA THERAPEUTICS, INC. | Directeur Financier/CFO | 01/08/2016 |
Formation de Allison Dorval
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
52
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Catalent JNP, Inc.
 Catalent JNP, Inc. Miscellaneous Commercial ServicesCommercial Services Specializes in research and development of drugs & therapeutics | Commercial Services |
iBASIS, Inc.
 iBASIS, Inc. Specialty TelecommunicationsCommunications Provides voice, mobile, messaging, IoT and cloud solutions | Communications |
Digitas, Inc.
 Digitas, Inc. Miscellaneous Commercial ServicesCommercial Services Provides digital and interactive marketing services | Commercial Services |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Commercial Services |
Arsenal Medical, Inc.
 Arsenal Medical, Inc. Medical SpecialtiesHealth Technology Develops biomaterials provides local therapy for important medical conditions across therapeutic areas | Health Technology |
University of Vermont
 University of Vermont Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Insulet Corp.
 Insulet Corp. Medical SpecialtiesHealth Technology Manufactures, develops and markets insulin infusion systems | Health Technology |
Puma Biotechnology, Inc.
 Puma Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a development stage company which develops biopharmaceuticals used for the treatment of cancer | Health Technology |
Lyra Therapeutics, Inc.
 Lyra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage therapeutics company which develops and commercializes novel integrated drugs for treatment of patients with ear, nose and throat and ENT diseases | Health Technology |
Voyager Therapeutics, Inc.
 Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
Verve Therapeutics, Inc.
 Verve Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat patients with cardiovascular disease | Health Technology |
Aerovate Therapeutics, Inc.
 Aerovate Therapeutics, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
